Derfor skal omhyggelig overvågning af faktor IX plasmaaktivitet og farmakokinetisk vurdering udføres for at justere doserne passende.
Therefore, close monitoring of factor IX plasma activity and pharmacokinetic assessment have to be performed in order to adjust doses as appropriate.